Bank of Nova Scotia
AGIO icon

Bank of Nova Scotia’s Agios Pharmaceuticals AGIO Stock Holding History

Bank of Nova Scotia’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,908
Closed -$503K – 1199
2021
Q3 		$503K Buy
+10,908
New +$527K ﹤0.01% 1001
2020
Q2 		– Sell
-35,936
Closed -$1.27M – 903
2020
Q1 		$1.27M Buy
35,936
+7,063
+24% +$326K ﹤0.01% 635
2019
Q4 		$1.38M Buy
+28,873
New +$1.09M ﹤0.01% 727

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Bank of Nova Scotia's AGIO Position: Q4 2021 in Review

Bank of Nova Scotia sold out of Agios Pharmaceuticals (AGIO) in Q4 2021, closing a stake of 10,908 shares — an estimated $503K sold.

Bank of Nova Scotia first reported a position in AGIO in Q4 2019 and held it in 3 quarters. The position peaked at $1.38M in Q4 2019. 161 funds tracked by Wall St. Rank hold AGIO as of Q4 2021.

  • Bank of Nova Scotia reported no remaining Agios Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Bank of Nova Scotia sold 10,908 Agios Pharmaceuticals shares in Q4 2021, an estimated $503K.
  • Bank of Nova Scotia first reported a position in Agios Pharmaceuticals in Q4 2019 and held it in 3 quarters.
  • Bank of Nova Scotia's Agios Pharmaceuticals position peaked at $1.38M in Q4 2019.
  • 161 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2021.

Based on Bank of Nova Scotia's 13F filing for Q4 2021, filed 11 Feb 2022.